FDA Tells 2 CBD Product Makers They May Be Violating The Food, Drug And Cosmetic Act

Mealey's (March 31, 2021, 8:25 AM EDT) -- SILVER SPRING, Md. — The Food and Drug Administration on March 22 announced that it issued warning letters to Honest Globe Inc. and BioLyte Laboratories LLC for selling cannabidiol (CBD) and for marketing their products in ways that may violate the Food, Drug and Cosmetic Act (FDCA), 21 U.S. Code § 301 et seq....

Related Sections